Combination therapy comprising Anti-angiogenesis agents and ox40 binding agonists

MA39817AUndetermined Publication Date: 2017-02-08F HOFFMANN LA ROCHE & CO AG +1

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA39817
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2015-02-06
Filing Date: 2015-03-30
Publication Date: 2017-02-08

Application Information

Patent Timeline

06 Feb 2015

Priority

30 Mar 2015

Application

MA39817

08 Feb 2017

Publication

MA39817A

IPC: A61K39/395; A61P35/00; C07K16/22; C07K16/28

CPC: A61K39/3955; A61K39/39558; A61K45/06; A61K48/00; C07K16/22; C07K16/2878; C07K16/30; C07K16/3069

Inventors: ANDYA James; BEVERS III Jack

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The disclosure provides compositions and methods for treating cancers. The method comprises administering an anti-angiogenesis agent and an ox40 binding agonist.

Need to check novelty before this filing date? Find Prior Art